Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 6/20 | 1.00 |
| ▸ | ADORA2A | P29274 | 4/20 | 1.00 |
| ▸ | TSHR | P16473 | 3/20 | 1.00 |
| ▸ | ADORA2B | P29275 | 3/20 | 1.00 |
| ▸ | ADORA1 | P30542 | 3/20 | 1.00 |
| ▸ | PMP22 | Q01453 | 2/20 | 1.00 |
| ▸ | SLC29A1 | Q99808 | 2/20 | 1.00 |
| ▸ | GAA | P10253 | 1/20 | 1.00 |
| ▸ | HTT | P42858 | 1/20 | 1.00 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 1.00 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | NFKB1 | P19838 | 1/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 1/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.98 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.98 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.98 |
| ▸ | THPO | P40225 | 1/20 | 0.98 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| N6-Cyclopentyladenosine SCHEMBL12226873 | 1.00 | ADORA3 (1.00) | ADORA3ADORA2ATSHRADORA2BADORA1 | |
| N6-Cyclopentyladenosine SCHEMBL7202975 | 1.00 | ADORA3 (1.00) | ADORA3ADORA2ATSHRADORA2BADORA1 | |
| N6-Cyclopentyladenosine SCHEMBL8271466 | 1.00 | ADORA3 (1.00) | ADORA3ADORA2ATSHRADORA2BADORA1 | |
| N6-Cyclopentyladenosine SCHEMBL381792 | 1.00 | ADORA3 (1.00) | ADORA3ADORA2ATSHRADORA2BADORA1 | |
| N6-Cyclopentyladenosine SCHEMBL472508 | 1.00 | ADORA3 (1.00) | ADORA3ADORA2ATSHRADORA2BADORA1 | |
| N6-Cyclopentyladenosine SCHEMBL472621 | 1.00 | ADORA3 (1.00) | ADORA3ADORA2ATSHRADORA2BADORA1 | |
| N6-Cyclopentyladenosine SCHEMBL12200134 | 1.00 | ADORA3 (1.00) | ADORA3ADORA2ATSHRADORA2BADORA1 | |
| N6-Cyclopentyladenosine SCHEMBL20226050 | 1.00 | ADORA3 (1.00) | ADORA3ADORA2ATSHRADORA2BADORA1 | |
| N6-Cyclopentyladenosine SCHEMBL18908968 | 1.00 | ADORA3 (1.00) | ADORA3ADORA2ATSHRADORA2BADORA1 | |
| SCHEMBL12119008 | 0.99 | TSHR (1.00) | ADORA3ADORA2ATSHRADORA2BADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 722 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250262274-A1 | Designed Biosensors for Enhanced T Cell Therapy | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) | 2025-08-21 | — | — | US | claimed |
| EP-4526335-A1 | DESIGNED BIOSENSORS FOR ENHANCED T CELL THERAPY | Centre Hospitalier Universitaire Vaudois (CH) | 2025-03-26 | — | — | EP | claimed |
| CN-118845814-A | Application of N6-cyclopentyl adenosine, derivatives and salts thereof in treating liver diseases | 上海中医药大学 | 2024-10-29 | — | — | CN | claimed |
| WO-2024182811-A1 | COMPOSITIONS AND METHODS FOR TREATING UTERINE LEIOMYOMAS | UNIVERSITY OF SOUTH FLORIDA (US) | 2024-09-06 | — | — | WO | claimed |
| US-20240024243-A1 | Fine Dry Particulate Adenosine Compositions and Topical Formulations Including the Same | LABORATORY SKIN CARE, INC. | 2024-01-25 | — | — | US | claimed |
| WO-2023222829-A1 | DESIGNED BIOSENSORS FOR ENHANCED T CELL THERAPY | CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS (CH) | 2023-11-23 | — | — | WO | claimed |
| CN-114376962-A | Drug-loaded nanofiber for acupuncture point thread embedding material and preparation method and application thereof | 上海市第四人民医院 | 2022-04-22 | — | — | CN | claimed |
| EP-3923962-A2 | GENE NETWORKS THAT MEDIATE REMYELINATION OF THE HUMAN BRAIN | University of Rochester (US) | 2021-12-22 | — | — | EP | claimed |
| WO-2021003393-A1 | METHOD, COMPOSITION, AND APPARATUS FOR TREATING HEADACHE | Equinox Ophthalmic, Inc. (US) | 2021-01-07 | — | — | WO | claimed |
| CN-111789950-A | Method and pharmaceutical composition for regulating fear memory consolidation | 浙江大学 | 2020-10-20 | — | — | CN | claimed |
| WO-2009018275-A1 | ADENOSINE AND ITS MIMETICS, MODULATORS, TRANSPORT INHIBITORS, AND RECEPTOR AGONISTS AS A THERAPEUTIC TOOL TO REPLACE OR IMPROVE THE EFFICACY OF DEEP BRAIN STIMULATION | UNIVERSITY OF ROCHESTER (US) | 2009-02-05 | — | — | WO | claimed |
| US-20070232560-A1 | Treatment of skin with adenosine or adenosine analog | UNIVERSITY OF MASSACHUSETTS, A MASSACHUSETTS CORPORATION | 2007-10-04 | — | — | US | claimed |
| US-20060240056-A1 | Treatment of skin with adenosine or adenosine analog | UNIVERSITY OF MASSACHUSETTS, A MASSACHUSETTS CORPORATION | 2006-10-26 | — | — | US | claimed |
| US-20060099568-A1 | Signals and molecular species involved in senescence | SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION (KR) | 2006-05-11 | — | — | US | claimed |
| JP-2004520404-A | — | — | 2004-07-08 | — | — | JP | claimed |
| EP-0996453-B1 | METHODS FOR THE INHIBITION OF NEURONAL ACTIVITY BY LOCAL DELIVERY OF ADENOSINE | MOHLER HANNS (CH) | 2004-04-28 | — | — | EP | claimed |
| WO-2003104482-A1 | SIGNALS AND MOLECULAR SPECIES INVOLVED IN SENESCENCE | METABOLIC ENGINEERING LABORATORIES CO., LTD. (KR) | 2003-12-18 | — | — | WO | claimed |
| EP-1363644-A2 | MODULATION OF GSK-3BETA ACTIVITY AND ITS DIFFERENT USES | Can-Fite Biopharma Ltd. (IL) | 2003-11-26 | — | — | EP | claimed |
| US-6638914-B1 | Use in inducing proliferation of the hematopoietic system, in particular, of bone marrow cells, comprising a pharmaceutically acceptable carrier, excipient or diluent and, as an active ingredient, an effective amount of an | CAN-FITE BIOPHARMA LTD. (IL) | 2003-10-28 | — | — | US | claimed |
| WO-2002066020-A2 | MODULATION OF GSK-3BETA ACTIVITY AND ITS DIFFERENT USES | CAN-FITE BIOPHARMA LTD. (IL) | 2002-08-29 | — | — | WO | claimed |